Issues & Trends

Not waiting for nature-positive standards, UK multinational GSK is taking action and a leadership role in the pharma and biotech sector. By Alastair Morton and Ellie Fallon.

The challenge is to reverse course, from causing nature loss to being “nature positive.” By Stacey Chow.

Satellite-based tracking of CO2 and methane emissions represent the dawn of a new era for business transparency, says Antoine Rostand, CEO of tracking platform Kayrros.

Preserving and restoring nature is a critical part of the climate solution. Brunswick asks two leaders of this effort to draw on their experience and highlight the role of business.

An introduction to the fourth edition of the Brunswick Social Value Review from the Editors in Chief.

While climate is a well-established concern, mass extinction and ecosystem collapse loom equally large—and businesses are beginning to respond.

As the European Commission gets set to review the EU’s pharmaceutical legislation, two issues demand particular attention: ensuring supplies of key medicines, especially antibiotics—and encouraging the innovation needed to maintain the therapeutic options available, which…

From a depth of experience that dates back to the hardscrabble 1940s, this prestige beauty industry legend surveys the world’s current travails and sees opportunity.

Venture philanthropy expert and public health advocate Olga Rudneva talks to us about helping Ukraine’s wounded become living symbols of a new country. By Maria Figueroa Küpçü and Carlton Wilkinson.

Downturns aren’t new to Silicon Valley, or to Abhinav Tiwari. By Kirsty Cameron.

United’s former Executive Chairman and CEO talks to Brunswick’s Jayne Rosefield about managing the airline’s turnaround and hard-won lessons of leadership. From the Brunswick Review.